Dr. Edwin D. Bryan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 701 Mcmeans Ave, Bay Minette, AL 36507 Phone: 251-937-1455 Fax: 251-937-1397 |
Abby Luray Nice, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Center Dr, Bay Minette, AL 36507 Phone: 251-937-6582 Fax: 251-937-6614 |
Bernard Scott Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1811 Hand Ave, Bay Minette, AL 36507 Phone: 251-937-7631 |
Baldwin Eye Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 1811 Hand Ave, Bay Minette, AL 36507 Phone: 251-937-7631 Fax: 251-937-7517 |
Dr. Kimberly Murray Dunagan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1811 Hand Ave, Bay Minette, AL 36507 Phone: 251-937-7631 Fax: 251-937-7517 |
William G Mcinnish, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2003 Medical Center Dr, Bay Minette, AL 36507 Phone: 251-937-6582 Fax: 251-937-6614 |
News Archive
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, achieved the first research milestone in its antibody therapeutics alliance with MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX), announced in February 2013.
Nearly two-thirds of deaths worldwide are caused by non-communicable diseases such as heart and lung disease, cancer, and diabetes, which are increasingly prevalent and cost the global economy trillions of dollars, according to a U.N. report and preliminary results from a new study announced Monday at a press conference to preview the September U.N. High Level Meeting on NCDs, the Associated Press/MSNBC.com reports.
Women recently diagnosed with breast cancer have higher survival rates than those diagnosed in previous decades, according to the American Cancer Society. However, survivors continue to face health challenges after their treatments end. Previous research reports as many as 50 percent of breast cancer survivors are depressed.
Thousands of cancer survivors could benefit from a new model of shared follow-up care delivered by specialist cancer care nurses, GPs, and cancer specialists incorporating telehealth sessions being implemented under a five-year $1.5 million NHMRC Investigator Grant.
Santarus, Inc. and Depomed, Inc. today announced that they have entered into a settlement agreement with Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, Inc., to resolve pending patent litigation involving GLUMETZA 1000 mg and 500 mg.
› Verified 3 days ago